Wearable device to increase physical activity amongst-adults with pain

  • Research type

    Research Study

  • Full title

    Wearable Technology for promoting physical activity in middle-aged adults with chronic musculoskeletal pain.

  • IRAS ID

    314666

  • Contact name

    John Hughes

  • Contact email

    john.hughes8@nhs.net

  • Sponsor organisation

    University of West London

  • Clinicaltrials.gov Identifier

    NCT05860478

  • Duration of Study in the UK

    1 years, 6 months, 31 days

  • Research summary

    Middle-aged adults with musculoskeletal chronic pain are often physically inactive. This inactivity is linked with constant pain, tiredness, and disability. National Institute for Health and Clinical Excellence (NICE) guidelines recommended group or individual based physical activity for patients with chronic pain. Wearable technology has been used as an intervention to motivate middle-aged adults to increase physical activity (PA), but its application on musculoskeletal chronic pain patients’ needs more investigation. The main research question: Is it acceptable to use wearable devices as an intervention to increase PA in middle-aged adults with musculoskeletal chronic pain? The purpose of this study is to evaluate the acceptability of all aspect of the research design of wearable device as an intervention to increase PA in middle-aged adults with musculoskeletal chronic pain.

    A mixed method randomised feasibility trial will be used in this study. Participants will be recruited from a National Health Service (NHS) pain clinic and randomised on a ratio1:3 into control group (standard care) and intervention group (standard care combined with wearable device). The feasibility study will last for 18 months, participants involvement will be for 24 weeks. Patients in both groups can participate in any physical activity, including planned, structured, and repetitive bodily movement exercise or occupational and recreational PA. Qualitative semi-structured interview will be conducted at baseline and week-12, while outcome measures will be conducted at baseline,4-week, 8-week,12-week, and 24-week for all participants to examine their pain, physical activity, and their responses to the trial. Qualitative interview will be conducted for stakeholders which include clinicians and service managers after all patient data collection has been completed. This study has the potential to make an original contribution to provide key data on the feasibility, acceptability, and effectiveness of using wearable technology to support physical activity intervention for middle-aged adults with musculoskeletal chromic pain.

  • REC name

    London - Queen Square Research Ethics Committee

  • REC reference

    22/LO/0816

  • Date of REC Opinion

    30 Jan 2023

  • REC opinion

    Further Information Favourable Opinion